Predictive Value and Correlation Study of HOMA2 IR-CP and TyG-BMI for

Introduction

In recent years, the global prevalence and incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) have been on a yearly upward trend, with the prevalence surging to as high as 37.8% post-2016.¹ Specifically,…